CGA
ZTS icon

Crescent Grove Advisors’s Zoetis ZTS Stock Holding History

Crescent Grove Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,479
Closed -$427K – 306
2023
Q2 		$427K Hold
2,479
– – 0.05% 189
2023
Q1 		$413K Sell
2,479
-37
-1% -$6.06K 0.05% 195
2022
Q4 		$369K Hold
2,516
– – 0.04% 209
2022
Q3 		$373K Hold
2,516
– – 0.04% 184
2022
Q2 		$432K Sell
2,516
-53
-2% -$9.17K 0.05% 171
2022
Q1 		$484K Buy
2,569
+53
+2% +$10.5K 0.05% 170
2021
Q4 		$614K Hold
2,516
– – 0.06% 156
2021
Q3 		$488K Buy
2,516
+804
+47% +$162K 0.05% 157
2021
Q2 		$319K Buy
+1,712
New +$297K 0.03% 186

Other funds holding ZTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Crescent Grove Advisors's ZTS Position: Q3 2023 in Review

Crescent Grove Advisors sold out of Zoetis (ZTS) in Q3 2023, closing a stake of 2,479 shares — an estimated $427K sold.

Crescent Grove Advisors first reported a position in ZTS in Q2 2021 and held it in 9 quarters. The position peaked at $614K in Q4 2021. 1,628 funds tracked by Wall St. Rank hold ZTS as of Q3 2023.

  • Crescent Grove Advisors reported no remaining Zoetis position as of Q3 2023 after selling out during the quarter.
  • Crescent Grove Advisors sold 2,479 Zoetis shares in Q3 2023, an estimated $427K.
  • Crescent Grove Advisors first reported a position in Zoetis in Q2 2021 and held it in 9 quarters.
  • Crescent Grove Advisors's Zoetis position peaked at $614K in Q4 2021.
  • 1,628 funds tracked by Wall St. Rank held Zoetis as of Q3 2023.

Based on Crescent Grove Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.